European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. Cited 25 September 2022].

Food and Drug Administration 84

Food and Drug Administration Pharmaceutical products Pharmacology FDA 84

PM360

JULY 27, 2022

PM360 Now Accepting Entries for 2022 Pharma Choice Awards. NEW YORK, NY, July 27, 2022 : The 2022 PM360 Pharma Choice Awards are officially open for entries. The complete 2022 PM360 Pharma Choice nomination criteria and online entry form is available at www.pm360online.com/pharmachoice. Contact: Kayla Walsh. 646-300-8114.

Pharma 52

Pharma Marketing Healthcare Healthcare 52

Pharmaceutical Technology

DECEMBER 5, 2022

On September 19, Lupkynis (voclosporin), a therapy for lupus nephritis (LN), received European Commission (EC) approval, becoming the second therapy approved in the EU for the treatment of LN after Benlysta (belimumab) from GlaxoSmithKline. Additionally, Benlysta recently showed that efficacy in LN was maintained beyond two years.

Food and Drug Administration 59

Food and Drug Administration Physicians Competition FDA 59

Pharmaceutical Technology

JANUARY 23, 2023

2022 The post Collaboration with Janssen and Eli Lilly to address lack of paediatric medications appeared first on Pharmaceutical Technology. Nelson RM, Conklin LS, Komocsar WJ, Chen F, Williamson F, Crandall WV. The Role of Master Protocols in Pediatric Drug Development. Ther Innov Regul Sci.

Medical 59

Medical Ethics Specialization Physicians 59

PM360

AUGUST 1, 2022

PM360’s 2022 December Innovations Issue Open for Submissions. NEW YORK, NY, August, 1, 2022 : Within the past couple of years, we have seen some of the greatest advancements ever made by the life sciences and healthcare industries. Senior Editor, PM360. 646-300-8113. andrew.matthius@pm360online.com.

Marketing 52

Marketing Healthcare Healthcare Education 52

PM360

AUGUST 17, 2022

PM360 Announces 2022 Trailblazer Award Finalists. Top Companies, Marketers, CEOs, Products, and Initiatives to be Honored During Gala on September 22 nd . NEW YORK, NY, August 17, 2022— PM360 has announced the finalists for its 14 th annual Trailblazer Awards. PHARMACEUTICAL/BIOTECH. Takeda Pharmaceutical Company.

Marketing 52

Marketing Healthcare Healthcare Education 52

PM360

SEPTEMBER 15, 2022

The delivery of medical education has changed and continues to evolve as new technology is developed and becomes more mainstream. Where clinicians once received information primarily from books, journals, and peers, HCPs today rely heavily on the digital delivery of new information.

Education 52

Education Media Medical Physicians 52